U.S. FDA considering additional round of boosters in the fall -official

WASHINGTON, March 29 (Reuters) – The U.S. Food and Drug Administration will weigh the benefits of authorizing a round of boosters of either the Pfizer/BioNTech or Moderna COVID-19 vaccine to a broader population in the fall, a top official said on Tuesday.

The agency authorized on Tuesday a second booster dose of either vaccine for older and immunocompromised people.

U.S. FDA considering additional round of boosters in the fall -official | Reuters